NCT07475767

Brief Summary

Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
3mo left

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Feb 2026Jul 2026

Study Start

First participant enrolled

February 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 9, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

March 16, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

March 9, 2026

Last Update Submit

March 12, 2026

Conditions

Keywords

Nutritional StatusRisk AssessmentUltrasonographyIntensive Care UnitsPostoperative Care

Outcome Measures

Primary Outcomes (13)

  • Clinical Frailty Scale

    The Clinical Frailty Scale (CFS) is a 9-point, clinician-judgment tool assessing fitness-to-frailty (1=Very Fit, 9=Terminally Ill).

    Day 1 (within 24 hours from admission to the intensive care unit)

  • Nutritional Risk Screening 2002

    The Nutritional Risk Screening 2002 (NRS-2002) is a rapid, validated tool designed by the European Society for Clinical Nutrition and Metabolism (ESPEN) to identify hospitalized patients at risk of malnutrition and requiring nutritional support. It calculates a total score (0-7) based on impaired nutritional status, disease severity, and age (≥70 years).

    Day 1

  • Vastus intermedius thickness

    Vastus intermedius thickness measured by ultrasound and expressed in centimeters.

    Day 1

  • Rectus femoris thickness

    Rectus femoris thickness measured by ultrasound and expressed in centimeters.

    Day 1

  • Vastus medialis thickness

    Vastus medialis thickness measured by ultrasound and expressed in centimeters.

    Day 1

  • Vastus lateralis thickness

    Vastus lateralis thickness measured by ultrasound and expressed in centimeters.

    Day 1

  • Vastus intermedius echogenicity

    Muscle echogenicity will be analyzed using ImageJ software and expressed as mean gray value.

    Day 1

  • Rectus femoris echogenicity

    Muscle echogenicity will be analyzed using ImageJ software and expressed as mean grey value.

    Day 1

  • Vastus medialis echogenicity

    Muscle echogenicity will be analyzed using ImageJ software and expressed as mean grey value.

    Day 1

  • Vastus lateralis echogenicity

    Muscle echogenicity will be analyzed using ImageJ software and expressed as the mean gray value.

    Day 1

  • Adipose tissue thickness

    Thickness of adipose tissue above quadriceps femoris muscle will be mesured by ultrasound and expressed in centimeters.

    Day 1

  • Body mass index ˙(BMI)

    Body Mass Index (BMI) is a screening tool that estimates body fat by dividing a person's weight in kilograms by the square of their height in meters (kg/m2)

    Perioperative

  • Length of mechanical ventilation

    Time from admission to the intensive care unit to the onset of spontaneous breathing. The time of admission to the intensive care unit is the start of mechanical ventilation. It lasts until extubation (removal of the endotracheal tube) and continuation of spontaneous breathing. It is expressed in hours. Whether the patient is intubated again, these two ventilation times are added together.

    One month from admission to the ICU.

Secondary Outcomes (4)

  • Haemoglobin

    Day 1

  • Albumin

    Day 1

  • C-reactive protein (CRP)

    Perioperative

  • Lactate

    Day 1

Study Arms (1)

Surgical patients in the intensive care unit

The prospective observational study will include consecutive patients admitted to the Department of Intensive Care of the Clinical Hospital Center in Osijek. Patients will be randomly included, regardless of age, gender, and type of surgical procedure. The study will be conducted after approval by the ethics committee of the Clinical Hospital Center in Osijek, and before inclusion in the study, the investigator will obtain informed consent from the patient or guardian. Patients who have had surgery on their right leg, on which muscle thickness and echogenicity will be measured, patients for whom informed consent is not obtained, and patients who are paraplegic will not be included in the study.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will be randomly selected patients admitted to the intensive care unit after undergoing a surgical procedure. These surgical procedures include abdominal, neurosurgical, plastic-reconstructive, traumatological, thoracic and maxillofacial surgeries. Patients will be included regardless of age, gender and whether the procedure was emergency or elective.

You may qualify if:

  • postoperative intensive care

You may not qualify if:

  • surgery of the right leg
  • paraplegia, tetraplegia
  • refusal of the patient/guardian to participate in the research (informed consent not signed)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Osijek University Hospital; Medical Faculty

Osijek, 31000, Croatia

RECRUITING

Related Publications (7)

  • Casey P, Alasmar M, McLaughlin J, Ang Y, McPhee J, Heire P, Sultan J. The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review. J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2298-2309. doi: 10.1002/jcsm.13041. Epub 2022 Jul 19.

    PMID: 35851996BACKGROUND
  • Xin C, Ma M, Wang Q, Li T, Sun Q, Jiang M, Du J, Li Z, Ma J. Correlation of ultrasound measurement of limb muscle thickness and echo intensity with frailty assessment in elderly patients undergoing malignancies surgery. Heliyon. 2024 Jan 3;10(1):e24017. doi: 10.1016/j.heliyon.2024.e24017. eCollection 2024 Jan 15.

    PMID: 38230231BACKGROUND
  • De Biasio JC, Mittel AM, Mueller AL, Ferrante LE, Kim DH, Shaefi S. Frailty in Critical Care Medicine: A Review. Anesth Analg. 2020 Jun;130(6):1462-1473. doi: 10.1213/ANE.0000000000004665.

    PMID: 32384336BACKGROUND
  • Kalaiselvan MS, Yadav A, Kaur R, Menon A, Wasnik S. Prevalence of Frailty in ICU and its Impact on Patients' Outcomes. Indian J Crit Care Med. 2023 May;27(5):335-341. doi: 10.5005/jp-journals-10071-24456.

    PMID: 37214110BACKGROUND
  • Bakshi N, Khurana A, Ferozi S. Nutrition Screening and Assessment among Critically Ill Patients [Internet]. Nutrition During Intensive Care. IntechOpen; 2024. https://doi.org/10.5772/intechopen.1007337

    BACKGROUND
  • Rohrig SAH, Lance MD, Faisal Malmstrom M. Surgical intensive care - current and future challenges? Qatar Med J. 2020 Jan 13;2019(2):3. doi: 10.5339/qmj.2019.qccc.3. eCollection 2019.

    PMID: 31976309BACKGROUND
  • Girgin T, Sayur V, Guler E, Uc C, Goktepe B, Ersin S, Uyar M, Sezer TO. Predictors of Mortality in Surgical Patients Admitted to a Tertiary Intensive Care Unit. J Clin Med. 2025 Sep 9;14(18):6369. doi: 10.3390/jcm14186369.

    PMID: 41010574BACKGROUND

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Slavica Kvolik, prof.

    Osijek University Hospital; Medical Faculty Osijek

    STUDY CHAIR

Central Study Contacts

Slavica Kvolik, prof.

CONTACT

Stjepan Juric, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2026

First Posted

March 16, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

March 16, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Yes, upon request sent to principal investigator

Shared Documents
STUDY PROTOCOL
Time Frame
After study publication.
Access Criteria
Upon the reasonable request sent to principal investigator.

Locations